Atlas Trials

Chronic Myeloproliferative Disorders

129 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Myeloproliferative Disorders

RecordFirmDate
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00290628)Masonic Cancer Center, University of Minnesota1999-10-01
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer (NCT00296023)University of California, San Francisco1999-01-01
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy (NCT00003600)Alliance for Clinical Trials in Oncology1998-12-01
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer (NCT00003816)Roswell Park Cancer Institute1998-10-19
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887)Fred Hutchinson Cancer Center1998-08-01
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer (NCT00003451)National Cancer Institute (NCI)1998-08-01
Treatment for Chronic Pain in Patients With Advanced Cancer (NCT00003687)NCIC Clinical Trials Group1998-06-11
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408)Cancer Treatment Centers of America1998-04-01
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia (NCT00003619)Drexel University College of Medicine1998-02-01
Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00003331)NYU Langone Health1998-01-01
Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer (NCT00003082)University of Arizona1997-12-01
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer (NCT00004036)The Cleveland Clinic1997-11-01
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors (NCT00003107)Indiana University1997-10-01
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation (NCT00005641)H. Lee Moffitt Cancer Center and Research Institute1997-09-01
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer (NCT00002980)California Cancer Consortium1997-05-01
Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders (NCT00002792)Fred Hutchinson Cancer Center1996-06-01
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant (NCT00005852)H. Lee Moffitt Cancer Center and Research Institute1996-06-01
Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders (NCT00005622)H. Lee Moffitt Cancer Center and Research Institute1996-05-01
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer (NCT00002742)Aronex Pharmaceuticals1996-01-01
Bone Marrow Transplant in Treating Patients With Hematologic Cancers (NCT00005797)H. Lee Moffitt Cancer Center and Research Institute1993-03-01
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma (NCT00900055)OHSU Knight Cancer Institute1975-06-01
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies (NCT01101412)M.D. Anderson Cancer Center
Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia (NCT00066417)National Heart, Lung, and Blood Institute (NHLBI)
← Previous

Track Chronic Myeloproliferative Disorders automatically

Every clearance here is in the API, with alerts when new ones post.